| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2024 | PSNL Personalis, Inc. | Tachibana Aaron68 | CFO And COO | Sell | 7,176 | $1.29 | $9,257.04 | -3.9% | +329.6% | +384.8% | |
| Jun 17, 2024 | PSNL Personalis, Inc. | Moore Stephen Michael52 | SVP And Chief Legal Officer | Sell | 1,585 | $1.29 | $2,044.65 | -2.2% | +329.6% | +384.8% | |
| Jun 17, 2024 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer And EVP | Sell | 5,055 | $1.29 | $6,520.95 | -3.8% | +329.6% | +384.8% | |
| Jun 17, 2024 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 7,683 | $28.31 | $217,505.73 | -7.8% | +36.0% | +130.9% | |
| Jun 17, 2024 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 2,646 | $28.31 | $74,908.26 | -6.6% | +36.0% | +130.9% | |
| Jun 14, 2024 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 95 | $51.04 | $4,848.41 | -0.1% | -10.6% | -32.7% | |
| Jun 14, 2024 | RDNT Radnet, Inc. | Levitt Lawrence L58 | - | Sell | 4,000 | $57.77 | $231,080.00 | -2.3% | +15.0% | -5.2% | |
| Jun 13, 2024 | BIO Bio-Rad Laboratories, Inc. | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 369 | $281.91 | $104,023.46 | -5.3% | +13.3% | -19.5% | |
| Jun 12, 2024 | RDNT Radnet, Inc. | Forthuber Stephen M49 | Pres &Coo-eastern Operations | Sell | 40,000 | $62.33 | $2,493,200.00 | -7.1% | -2.3% | -8.4% | |
| Jun 12, 2024 | RDNT Radnet, Inc. | Murdock Michael N45 | EVP, Mergers And Acquisitions | Sell | 10,000 | $62.51 | $625,100.00 | -13.7% | -2.3% | -8.4% | |
| Jun 12, 2024 | WST West Pharmaceutical Services Inc | Abraham Silji62 | SVP, Chief Technology Officer | Sell | 1,800 | $330.78 | $595,404.00 | -38.6% | -9.7% | -33.5% | |
| Jun 12, 2024 | RDNT Radnet, Inc. | Sorensen Alma Gregory59 | EVP, Chief Science Officer | Sell | 15,000 | $61.97 | $929,600.00 | -0.6% | -2.3% | -8.4% | |
| Jun 12, 2024 | RDNT Radnet, Inc. | Hames Norman R56 | Pres And Coo-west Operations | Sell | 73,597 | $61.75 | $4,544,798.76 | -8.6% | -2.3% | -8.4% | |
| Jun 12, 2024 | RDNT Radnet, Inc. | Swartz David L | - | Sell | 25,000 | $60.75 | $1,518,841.34 | -5.9% | -2.3% | -8.4% | |
| Jun 11, 2024 | VCYT Veracyte, Inc. | Eastham Karin67 | Director | Sell | 3,870 | $20.59 | $79,683.30 | -11.7% | +36.6% | +31.2% | |
| Jun 10, 2024 | RDNT Radnet, Inc. | Levitt Lawrence L58 | - | Sell | 16,000 | $60.85 | $973,600.00 | -8.4% | -1.0% | -3.6% | |
| Jun 10, 2024 | RDNT Radnet, Inc. | Stolper Mark | EVP, Chief Financial Officer | Sell | 25,000 | $61.27 | $1,531,750.00 | -23.7% | -1.0% | -3.6% | |
| Jun 10, 2024 | A Agilent Technologies, Inc. | Grau Dominique70 | Senior Vice President | Sell | 15,000 | $133.28 | $1,999,261.50 | -23.3% | +3.8% | -9.4% | |
| Jun 10, 2024 | VCYT Veracyte, Inc. | Bhanji Muna59 | Director | Sell | 3,870 | $20.32 | $78,633.76 | -14.3% | +39.3% | +33.5% | |
| Jun 10, 2024 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 2,652 | $24.92 | $66,087.84 | -3.2% | +31.3% | +170.7% | |
| Jun 10, 2024 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 895 | $24.92 | $22,303.40 | -2.7% | +31.3% | +170.7% | |
| Jun 10, 2024 | RDNT Radnet, Inc. | Gordon Christine Nayoma | - | Sell | 4,500 | $61.21 | $275,445.00 | -16.2% | -1.0% | -3.6% | |
| Jun 7, 2024 | VCYT Veracyte, Inc. | Eastham Karin67 | Director | Sell | 2,500 | $20.97 | $52,425.00 | -7.0% | +44.2% | +33.0% | |
| Jun 7, 2024 | RVTY Revvity, Inc. | Goldberg Joel S58 | Please See Remarks | Sell | 4,000 | $110.46 | $441,844.48 | -5.1% | +5.6% | -17.1% | |
| Jun 7, 2024 | RDNT Radnet, Inc. | Katz David Jeffrey48 | EVP And Chief Legal Officer | Sell | 16,400 | $61.26 | $1,004,664.00 | -20.0% | +3.2% | -4.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.